期刊文献+

OGP_(10~14)及其衍生物改善化疗后小鼠造血功能的研究

The Effects of OGP_(10~14) and its Derivatives on Hematopoiesis in Mice Treated By Cyclophosphamide
下载PDF
导出
摘要 目的观察人工合成的成骨生长肽羧基端片段(OGP(10~14))及其衍生物G38I、G38K对环磷酰胺化疗后骨髓抑制小鼠外周血象和骨髓造血功能的影响。方法 40只BALB/C小鼠随机分为5组,均给予环磷酰胺(CTX)腹腔注射诱导骨髓抑制。分别给予OGP(10~14)、G38I、G38K或粒细胞集落刺激因子(G-CSF)治疗,未给予治疗的CTX组为阴性对照。实验中多次采集小鼠外周血测定外周血象并于注射CTX后第7天处死。观察骨髓有核细胞数的变化。结果 CTX组小鼠注射CTX后外周血白细胞和血小板下降,出现骨髓造血抑制。注射CTX前OGP(10~14)及其衍生物对小鼠外周血象无明显影响。注射CTX后OGP(10~14)组和G38I组外周血白细胞较CTX组显著升高,疗效与G-CSF接近,G38I组和G38K组血小板升高。OGP(10~14)及其衍生物G38I、G38K和G-CSF处理使小鼠骨髓有核细胞数增多,OGP(10~14)和G38I疗效更优于G38K。结论 OGP(10~14)及其衍生物G38I、G38K促进骨髓抑制小鼠外周血白细胞和血小板升高,刺激骨髓造血干细胞活性,加速骨髓造血功能的恢复。 Objective To investigate the effects of OGP(10-14) and its derivatives G38I, G38K on peripheral blood and bone marrow hematopoiesis in mice av.ated by cyclophosphamide(CTX). Methods Forty BALB/C mice were randomly divided into 5 groups. The marrow ablation was carded out by intraperitoneal injection of CTX. The mice were treated by OGP(10-14), G38I, G38K or granulocyte-colony stimulating factor(G-CSF) respectively while the CTX group was negative control. The peripheral blood were collected and cells counts were performed four times on the same animal before and after CTX injection. All mice were sacrificed on the 7th day after CTX injection. Bone marrow nucleated cells(BMNC) were studied. Results The white blood cells(WBC) and platelets(PLT)counts decreased after CTX injection in CTX group. OGP(10-14) and its derivatives hadn't significant effects on peripheral blood before CTX injection but the WBC counts of OGP(10-14) and G38I were increased compared with that in CTX group and similar with G-CSF treated group after CTX injection. PLT were increased in G38I and G38K groups. The BMNC were increased in OGP(10-14), G38I, G38K and G-CSF group. Between the treated groups, OGP(10-14) and G38I were more efficient compared to G38K. Conclusion OGP(10-14) and its derivatives G38I, G38K may enhance the WBC and PLT of peripheral blood in mice with bone marrow injury, mobilized the hematopoific stem cells and accelerate recovery of hematopoiesis of bone marrow.
出处 《中国医药指南》 2010年第14期5-7,共3页 Guide of China Medicine
基金 国家自然科学基金资助项目(项目编号:30271530)
关键词 成骨生长肽羧基端片段 衍生物 外周血 骨髓有核细胞 Osteogenic growth peptide c-terminal pentapeptide Derivative Peripheral blood Bone marrow nucleated cell
  • 相关文献

参考文献13

  • 1Bab I,Chorev M.Osteogenic growth peptide:from concept to drug design[J].Biopolymers,2002,66(1):33-48.
  • 2Gurevitch O,Slavin S,Muhlrad A,et al.Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice[J].Blood,1996,88(12):4719-4724.
  • 3Spreafico A,Frediani B,Capperucci C,et al.Osteogenic growth peptide effects on primary human osteoblast cultures:potential relevance for the treatment of glucocorticoid-induced osteoporosis[J].J Cell Biochem 306,98(4):1007-1020.
  • 4Chen YC,Muhlrad A,Shteyer A,et al.Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide,OGP(10-14)[J].J Med Chem,2002,45(8):1624-1632.
  • 5Fazzi R,Galimberti S,Testi R,et al.Bone and bone marrow interactions:hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide.Ⅱ.Action on human hematopoietic stem cells[J].Leuk Res,2002,26(9):839-848.
  • 6吴友苹,张升,陈雁虹,吴洪海,俞亚南.环磷酰胺两次间隔注射给药对正常大鼠免疫功能的影响[J].癌变.畸变.突变,2009,21(6):443-446. 被引量:7
  • 7张擎,彭红娟,余晓彬,徐培林.环磷酰胺诱发小鼠血小板减少症模型的建立及其血小板功能的测定[J].第一军医大学学报,2003,23(12):1277-1279. 被引量:25
  • 8刘远莉,李冀宏,张宇雯,马洪星,栗亚,刘兴汉.重组人成骨生长肽对化疗小鼠白细胞减少的影响[J].哈尔滨医科大学学报,2007,41(4):320-323. 被引量:3
  • 9Fazzi R,Testi R,Trasciatti S,et al.Bone and bone-marrow interactions:haematological activity of osteoblastic growth peptide-derived carboxy-terminal pentapeptide.Mobilizing properties on white blood cells and peripheral blood stem cells in mice[J].Leuk Res,2002,26(1):19-27.
  • 10邵云潮,陈红红,刘智慧,施德源,催大敷,陈统一,陈中伟.成骨生长肽促进化疗小鼠造血功能的恢复[J].复旦学报(医学版),2003,30(2):132-136. 被引量:4

二级参考文献26

  • 1余琼,周凌云,林雪松,徐建永,王淑静,刘兴汉.重组人成骨生长肽的表达、纯化和活性的研究[J].中国生物化学与分子生物学报,2004,20(4):467-472. 被引量:14
  • 2赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:79
  • 3刘继彦,李永强,彭瑞清,丁娅,李鸿立,程霞,张念华,张晓实,曾益新.环磷酰胺单次注射对小鼠淋巴细胞及其亚群的早期作用[J].中国肿瘤生物治疗杂志,2005,12(3):179-182. 被引量:17
  • 4Matar P, Rozados VR, Gonzalez AD, et al. Mechanism of antimetastatic immunopotentiation by low-dose cyclophoshamidem [J ]. European J Cancer, 2000,36(8) : 1060 - 1066.
  • 5Shivola M, Sistonen L, Alitalo K, et al. Mechanism of T cell proliferation in vivo: analysis of IL-2 receptor expression and activation of c-myc and c-myb oncogenes during lymphatic regeneration [ J ] . Biochem Biophys Res Commun, 1989,160(1) : 180- 188.
  • 6Matar P, Rozados VR, Gervasoni SI, et al.Th1/Th2 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma mode[J] .Cancer Immunol Immunather, 2002, 50(11) :588- 596.
  • 7Castano AP, Mroz P, Wu MX, et al. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model[J]. Proc Natl Acad Sci USA, 2008, 105(14): 5495 - 5500.
  • 8Turk JL, Parker D, Cameron AE.The effect of cyclophosphamide on immunological control mechanisms[J] . Int J Tissue React,1984, 6 (3) :205- 211.
  • 9Ghiringhelli F, Larmonier N, Schmitt E, et al. CD4^-CD25^+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows established tumors to be curative [ J ] . Eur immunotherapy of J Immunol, 2004,34(2):336- 344.
  • 10Tzai TS, Johnny SN, Chow NH. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide [J] .J Surgical Res, 1996,65(2) : 139- 144.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部